Quality of life of children with atopic dermatitis and their families
The DOI matches its Crossref record; 21 of the 22 references it cites were found in a registry or an index.
Abstract
PURPOSE OF THE REVIEW: Over the last few years major advances have been made in the conceptualization of quality of life and new instruments have been developed for assessing the construct in paediatric atopic dermatitis. This review looks at these developments and reports on recently published articles on the impact of the condition on affected children and other members of their family. RECENT FINDINGS: During the period of the review only one article addressing the impact of treatment for paediatric atopic dermatitis on quality of life could be found. This showed the benefits to the quality of life of parents of treating their children with pimecrolimus cream. SUMMARY: Given the prevalence of paediatric atopic dermatitis and its impact on affected children and their families it is surprising that so little attention has been devoted to the impact of treatment on quality of life. Where standardized measures are included in studies they generally assess outcomes that are of interest to physicians rather than to patients and their carers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The disorder results in significant morbidity and adversely affects quality of life [2].”
From Atopic dermatitis (2018) · cites this paper as [2]
In the citing paper
“Regardless of age, the itching associated with AD generally continues throughout the day and worsens at night, leading to sleep loss and substantial impairments in quality of life [2, 9].”
From Atopic dermatitis (2018) · cites this paper as [2]
Citations
Cites
The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use
LEWIS-JONES, M. S., & FINLAY, A. Y. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1995.tb16953.x · Cited by 1,051
The family impact of childhood atopic dermatitis: The Dermatitis Family Impact Questionnaire
Lawson, Lewis-Jones, Finlay, Reid, & Owens (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02034.x · Cited by 434
The Infants’ Dermatitis Quality of Life Index
Lewis-Jones, M. S., Finlay, A. Y., & Dykes, P. J. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.03960.x · Cited by 384
Grimalt, R., Mengeaud, V., & Cambazard, F. (2007) · Dermatology · doi:10.1159/000096915 · Cited by 245
Psychosocial adjustment in preschool children with atopic eczema.
Daud, L. R., Garralda, M. E., & David, T. J. (1993) · Archives of Disease in Childhood · doi:10.1136/adc.69.6.670 · Cited by 202
Defining Patient-Reported Outcomes
Doward, L. C., & McKenna, S. P. (2004) · Value in Health · doi:10.1111/j.1524-4733.2004.7s102.x · Cited by 193
Self-citationFölster-Holst, R., Müller, F., Schnopp, N., Abeck, D., Kreiselmaier, I., Lenz, T., Von Rüden, U., Schrezenmeir, J., Christophers, E., & Weichenthal, M. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07558.x · Cited by 166
Psychosocial Aspects of Disease
LIPOWSKI, Z. J. (1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-71-6-1197 · Cited by 124
Ricci, G., Bendandi, B., Bellini, F., Patrizi, A., & Masi, M. (2007) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2006.00502.x · Cited by 120
Beattie, P. E., & Lewis-Jones, M. S. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07525.x · Cited by 115
Research works printed but not linked: 3
- Finlay, 1992, Quality of life impairment in atopic dermatitis and psoriasis, Clinical and Experimental Perspectives in Sandimmun Therapy, 2, 10
- Von Rueden, 1999, Development and validation of a disease specific questionnaire on quality of life of parents of children with atopic dermatitis, Z F Gesundheitswiss, 4, 335
- McKenna, 2006, Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel®, SDZ ASM 981): Impact on quality of life and health-related quality of life, JEADV, 20, 248
Cited by
Thaçi, D., Simpson, E. L., Beck, L. A., Bieber, T., Blauvelt, A., Papp, K., Soong, W., Worm, M., Szepietowski, J. C., Sofen, H., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00388-8 · Cited by 572
Hamilton, J. D., Suárez-Fariñas, M., Dhingra, N., Cardinale, I., Li, X., Kostic, A., Ming, J. E., Radin, A. R., Krueger, J. G., Graham, N., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.10.013 · Cited by 469
Simpson, E. L., Bieber, T., Eckert, L., Wu, R., Ardeleanu, M., Graham, N. M. H., Pirozzi, G., & Mastey, V. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.10.043 · Cited by 302
Dupilumab for treatment of atopic dermatitis
Seegräber, M., Srour, J., Walter, A., Knop, M., & Wollenberg, A. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1449642 · Cited by 222
“Atopic dermatitis affects the life quality of patients tremendously, especially in more severe cases [8,9].”
BackgroundKapur, S., Watson, W., & Carr, S. (2018) · Allergy, Asthma & Clinical Immunology · doi:10.1186/s13223-018-0281-6 · Cited by 175
“The disorder results in significant morbidity and adversely affects quality of life [2].”
Background
Metadata
- Authors
- McKenna, S. P., & Doward, L. C.
- Affiliations
- University of Lancashire (GB)
- Corresponding author
- McKenna, Stephen P
- Venue
- Current Opinion in Allergy & Clinical Immunology
- Published
- 2008-06
- Volume
- 8
- Issue
- 3
- Pages
- 228-231
- ISSN
- 1473-6322 (ISSN-L)
- 1528-4050
- OpenAlex
- W2092702041
- Cited by
- 74
- References
- 22
- Citations by year
- 2024: 6 · 2023: 1 · 2022: 5 · 2021: 5 · 2020: 6 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 6 · 2015: 9 · 2014: 5 · 2013: 5 · 2012: 3
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Allergy and Clinical Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- pediatric atopic dermatitis, quality of life, children, family, quality of life instruments, pimecrolimus, treatment effects, patient-reported outcomes
- MeSH terms
- Child, Clinical Trials as Topic, Dermatitis, Atopic, Family, Health Status, Health Status Indicators, Humans, Quality of Life, Surveys and Questionnaires, Severity of Illness Index, Treatment Outcome, Cost of Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quality of life of children with atopic dermatitis and their families. https://app.cochat.ai/papers/10.1097/aci.0b013e3282ffd6cc
- The paper
- McKenna, S. P., & Doward, L. C. (2008). Quality of life of children with atopic dermatitis and their families. Current Opinion in Allergy & Clinical Immunology. https://doi.org/10.1097/aci.0b013e3282ffd6cc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.